Literature DB >> 33479372

Relationship of breast volume, obesity and central obesity with different prognostic factors of breast cancer.

Daniel María Lubián López1, Carmen Aisha Butrón Hinojo2, María Castillo Lara3, Manuel Sánchez-Prieto4, Rafael Sánchez-Borrego5, Nicolas Mendoza Ladrón de Guevara6, Ernesto González Mesa7.   

Abstract

The objective of this study was to investigate whether the BC tumor biology in women with larger breast volume, in obese women and especially in women with central adiposity at the moment of diagnosis of BC is more aggressive than in those women without these characteristics. 347 pre- and postmenopausal women with a recent diagnosis of BC were analyzed. In all patients, anthropometric measurements at the time of diagnosis was collected. In 103 of them, the breast volume was measured by the Archimedes method. The Breast volume, BMI, WHR and the menopausal status were related to different well-known pathological prognostic factors for BC. At the time of diagnosis, 35.4% were obese (BMI > 30 kg/m2), 60.2% had a WHR ≥ 0.85, 68.8% were postmenopausal and 44.7% had a breast volume considered "large" (> 600 cc). Between patients with a large breast volume, only a higher prevalence of ER (+) tumors was found (95.3% vs. 77.2%; p = 0.04) compared to those with small breast volumes. The obese BC patients showed significantly higher rates of large tumors (45.5% vs. 40.6%; p = 0.04), axillary invasion (53.6% vs. 38.8%; p = 0.04), undifferentiated tumors (38.2% vs. 23.2%) and unfavorable NPI (p = 0.04) than non-obese women. Those with WHR ≥ 0.85 presented higher postsurgical tumor stages (61.7% vs. 57.8%; p = 0.03), higher axillary invasion (39.9% vs. 36.0%; p = 0.004), more undifferentiated tumors (30.0% vs. 22.3%; p = 0.009), higher lymphovascular infiltration (6.5% vs. 1.6%; p = 0.02), and a higher NPI (3.6 ± 1.8 vs. 3.2 ± 1.8; p = 0.04). No statistically significant differences were found according to menopausal status. We conclude that obesity, but especially central obesity can be associated with a more aggressive tumour phenotype. No relation between breast volume and tumoral prognostic factors was found, except for a higher proportion of ER (+) tumor in women with higher breast volume.

Entities:  

Year:  2021        PMID: 33479372      PMCID: PMC7820412          DOI: 10.1038/s41598-021-81436-9

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  48 in total

1.  Association of body size measurements and mammographic density in Korean women: the Healthy Twin study.

Authors:  Joohon Sung; Yun-Mi Song; Jennifer Stone; Kayoung Lee; Sun-Young Kim
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-05-25       Impact factor: 4.254

Review 2.  Epidermal growth factor receptor/HER2/insulin-like growth factor receptor signalling and oestrogen receptor activity in clinical breast cancer.

Authors:  J M Gee; J F Robertson; E Gutteridge; I O Ellis; S E Pinder; M Rubini; R I Nicholson
Journal:  Endocr Relat Cancer       Date:  2005-07       Impact factor: 5.678

3.  Breast size in relation to endogenous hormone levels, body constitution, and oral contraceptive use in healthy nulligravid women aged 19-25 years.

Authors:  H Jernström; H Olsson
Journal:  Am J Epidemiol       Date:  1997-04-01       Impact factor: 4.897

4.  Lifetime adult weight gain, central adiposity, and the risk of pre- and postmenopausal breast cancer in the Western New York exposures and breast cancer study.

Authors:  Daikwon Han; Jing Nie; Matthew R Bonner; Susan E McCann; Paola Muti; Maurizio Trevisan; Farah A Ramirez-Marrero; Dominica Vito; Jo L Freudenheim
Journal:  Int J Cancer       Date:  2006-12-15       Impact factor: 7.396

5.  Circulating concentrations of insulin-like growth factor-I and risk of breast cancer.

Authors:  S E Hankinson; W C Willett; G A Colditz; D J Hunter; D S Michaud; B Deroo; B Rosner; F E Speizer; M Pollak
Journal:  Lancet       Date:  1998-05-09       Impact factor: 79.321

6.  Stage of breast cancer in relation to body mass index and bra cup size.

Authors:  H I Hall; R J Coates; R J Uhler; L A Brinton; M D Gammon; D Brogan; N Potischman; K E Malone; C A Swanson
Journal:  Int J Cancer       Date:  1999-07-02       Impact factor: 7.396

Review 7.  Hormonal control of regional fat distribution.

Authors:  P Björntorp
Journal:  Hum Reprod       Date:  1997-10       Impact factor: 6.918

8.  Body size and breast cancer risk: findings from the European Prospective Investigation into Cancer And Nutrition (EPIC).

Authors:  Petra H Lahmann; Kurt Hoffmann; Naomi Allen; Carla H van Gils; Kay-Tee Khaw; Bertrand Tehard; Franco Berrino; Anne Tjønneland; Janne Bigaard; Anja Olsen; Kim Overvad; Françoise Clavel-Chapelon; Gabriele Nagel; Heiner Boeing; Dimitrios Trichopoulos; George Economou; George Bellos; Domenico Palli; Rosario Tumino; Salvatore Panico; Carlotta Sacerdote; Vittorio Krogh; Petra H M Peeters; H Bas Bueno-de-Mesquita; Eiliv Lund; Eva Ardanaz; Pilar Amiano; Guillem Pera; José R Quirós; Carmen Martínez; María J Tormo; Elisabet Wirfält; Göran Berglund; Göran Hallmans; Timothy J Key; Gillian Reeves; Sheila Bingham; Teresa Norat; Carine Biessy; Rudolf Kaaks; Elio Riboli
Journal:  Int J Cancer       Date:  2004-09-20       Impact factor: 7.396

9.  Body weight and incidence of breast cancer defined by estrogen and progesterone receptor status--a meta-analysis.

Authors:  Reiko Suzuki; Nicola Orsini; Shigehira Saji; Timothy J Key; Alicja Wolk
Journal:  Int J Cancer       Date:  2009-02-01       Impact factor: 7.396

10.  Breast size and risk of type 2 diabetes mellitus.

Authors:  Joel G Ray; Anshu P Mohllajee; Rob M van Dam; Karin B Michels
Journal:  CMAJ       Date:  2008-01-29       Impact factor: 8.262

View more
  1 in total

Review 1.  The Influence of Modifiable Factors on Breast and Prostate Cancer Risk and Disease Progression.

Authors:  Keely Tan; Matthew J Naylor
Journal:  Front Physiol       Date:  2022-03-07       Impact factor: 4.566

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.